NeuroSearch and GSK in Depression Deal
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 32 (Table of Contents)
Published: 3 Jan-2003
DOI: 10.3833/pdr.v2003.i32.954 ISSN: 1756-7874
Section: General
Abstract
NeuroSearch entered into a deal with GlaxoSmithKline (GSK) that provided GSK an option on compounds arising from NeuroSearch’s research into the use of triple action monoamine reuptake inhibitors to treat depression...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018